Low serum T and active surveillance: let’s look before we leap

A new report from a group of Italian researchers has suggested that circulating serum testosterone (T) levels in the blood may be a risk for upgrading and upstaging among men initially diagnosed with low-risk prostate cancer who are managed on active surveillance. … READ MORE …

91 percent of Swedish men diagnosed with very low-risk prostate cancer now start on active surveillance

According to a new paper, just published in JAMA Oncology, the vast majority of Swedish men diagnosed with very low- and low-risk prostate cancer are now being initially managed on active surveillance. … READ MORE …

Active surveillance in practice: probably not good enough as yet

As we have noted more than once before, a major problem with being managed on active surveillance is (potentially) whether one’s clinical management team really has been trained to conduct active surveillance in a sufficiently active manner. … READ MORE …

mpMRIs, MRI/TRUS fusion-guided biopsies, and systematic biopsies in monitoring of men on active surveillance

A new article in the Journal of Urology has provided us with some initial insight into the value of multiparametric MRIs (mpMRIs) in monitoring progression of patients on active surveillance protocols. … READ MORE …

Refining the criteria for selection of patients suitable for active surveillance

The question of how best to set the spectrum of criteria that indicate the suitability of an individual patient as a good candidate for active surveillance as opposed to early treatment is (as yet) not well answered. … READ MORE …

Tales from “a poster boy” for active surveillance

Howard Wolinksy is  a journalist — by training and by profession. In 2010, a while after he finished full-time employment with the Chicago Sun-Times, he was diagnosed with low-risk prostate cancer, and he has been documenting the impact ever since. … READ MORE …

The role of active surveillance in prostate cancer management today

There is a new and very sound article by Gina Kolata in The New York Times (published online yesterday) addressing the expanding role of active surveillance as an initial management option for low-risk forms of prostate cancer. … READ MORE …